Testing effectiveness (Phase 2)Study completedNCT01955694
What this trial is testing
Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone
Who this might be right for
Heart Failure
Bayer 72